The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using the company’s QuEEN platform, that makes ...

The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...

You see, while incense sticks has been used for thousands of years by a number of different cultures for their intense, powerful scenting abilities, nowadays we are seeing brands from Loewe to ...